Thu, January 28, 2021

David Risinger Maintained (ABBV) at Buy with Decreased Target to $116 on, Jan 28th, 2021

David Risinger of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $120 to $116 on, Jan 28th, 2021.

David has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020


These are the ratings of the 6 analyists that currently disagree with David


  • Randall Stanicky of "RBC Capital" Initiated at Buy and Held Target at $129 on, Wednesday, January 6th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $128 on, Wednesday, December 16th, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020